基于病例的《2017年欧洲心脏病学会冠状动脉疾病双联抗血小板治疗重点更新》实施情况 - Suppr

Suppr

超能文献

Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.

作者信息

Collet Jean-Philippe, Roffi Marco, Byrne Robert A, Costa Francesco, Valgimigli Marco

出版信息

Eur Heart J. 2018 Jan 14;39(3):e1-e33. doi: 10.1093/eurheartj/ehx503.

DOI:10.1093/eurheartj/ehx503

PMID:29088328

Abstract

摘要

相似文献

Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.基于病例的《2017年欧洲心脏病学会冠状动脉疾病双联抗血小板治疗重点更新》实施情况

Eur Heart J. 2018 Jan 14;39(3):e1-e33. doi: 10.1093/eurheartj/ehx503.

[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.].[2017年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的冠状动脉疾病双联抗血小板治疗重点更新版。]

Kardiol Pol. 2017;75(12):1217-1299. doi: 10.5603/KP.2017.0224.

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).2017年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的冠状动脉疾病双联抗血小板治疗重点更新：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）冠状动脉疾病双联抗血小板治疗特别工作组。

Eur Heart J. 2018 Jan 14;39(3):213-260. doi: 10.1093/eurheartj/ehx419.

[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: What is new?].[2017年欧洲心脏病学会与欧洲心胸外科协会合作制定的冠状动脉疾病双联抗血小板治疗重点更新：有哪些新内容？]

Turk Kardiyol Dern Ars. 2018 Jan;46(1):1-6. doi: 10.5543/tkda.2017.77775.

Focused Update on Duration of Dual Antiplatelet Therapy for Patients With Coronary Artery Disease.冠状动脉疾病患者双联抗血小板治疗持续时间的重点更新

JAMA Cardiol. 2016 Sep 1;1(6):733-4. doi: 10.1001/jamacardio.2016.2171.

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.2017年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的冠状动脉疾病双联抗血小板治疗重点更新内容。

Eur J Cardiothorac Surg. 2018 Jan 1;53(1):34-78. doi: 10.1093/ejcts/ezx334.

Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease-a review.2017年欧洲心脏病学会冠状动脉疾病双重抗血小板治疗指南的变化与创新——综述

Wien Klin Wochenschr. 2018 Dec;130(23-24):694-697. doi: 10.1007/s00508-018-1357-5. Epub 2018 Jul 20.

Challenges of antiplatelet therapy in patients who require anticoagulation.需要抗凝治疗的患者抗血小板治疗面临的挑战。

J Invasive Cardiol. 2009 Apr;21(4):186-9.

The role of antiplatelet therapy in the secondary prevention of coronary artery disease.抗血小板治疗在冠心病二级预防中的作用。

Curr Opin Cardiol. 2010 Jul;25(4):321-8. doi: 10.1097/HCO.0b013e328338f7b5.

An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events.氯吡格雷与阿司匹林双联抗血小板治疗预防心血管事件的评估

J Am Board Fam Med. 2009 Jan-Feb;22(1):51-6. doi: 10.3122/jabfm.2009.01.070282.

引用本文的文献

Real-world analysis of characteristics and guideline adherence of antiplatelet drugs prescriptions among patients with coronary artery disease and its comorbidities: a cross-sectional study.冠心病及其合并症患者抗血小板药物处方特征与指南依从性的真实世界分析：一项横断面研究

BMC Cardiovasc Disord. 2025 Aug 14;25(1):604. doi: 10.1186/s12872-025-05046-3.

Patient Transfer Process From Pre-Hospital to the Hospital Emergency Department: A Grounded Theory Study.从院前到医院急诊科的患者转运过程：一项扎根理论研究。

Nurs Open. 2025 Jul;12(7):e70190. doi: 10.1002/nop2.70190.

Antithrombotic Therapy in Patients Undergoing Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术患者的抗栓治疗

J Clin Med. 2024 Jun 21;13(13):3636. doi: 10.3390/jcm13133636.

The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome.急性冠状动脉综合征管理的发展领域：对2023年欧洲心脏病学会急性冠状动脉综合征管理指南的批判性评估

J Clin Med. 2024 Mar 25;13(7):1885. doi: 10.3390/jcm13071885.

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease.年龄与阿司匹林剂量在动脉粥样硬化性心血管疾病二级预防中的应用

J Am Heart Assoc. 2024 Feb 20;13(4):e026921. doi: 10.1161/JAHA.122.026921. Epub 2024 Feb 13.

Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review.冠状动脉支架置入术后双联抗血小板治疗疗程的个体化：一项全面的、基于证据的综述

J Clin Med. 2023 Nov 17;12(22):7144. doi: 10.3390/jcm12227144.

Impacts of Omaha System-Based Continuing Care on the Medication Compliance, Quality of Life, and Prognosis of Coronary Heart Disease Patients After PCI.奥马哈系统为基础的延续护理对经皮冠状动脉介入治疗后冠心病患者的药物依从性、生活质量和预后的影响。

Braz J Cardiovasc Surg. 2022 Aug 16;37(4):472-480. doi: 10.21470/1678-9741-2021-0222.

Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease.优化慢性肾脏病患者经皮冠状动脉介入治疗的结局

J Clin Med. 2022 Apr 23;11(9):2380. doi: 10.3390/jcm11092380.

Effects of IL-32 polymorphisms and IL-32 levels on the susceptibility and severity of coronary artery disease.白细胞介素 32 多态性和白细胞介素 32 水平对冠心病易感性和严重程度的影响。

J Clin Lab Anal. 2022 Jan;36(1):e24114. doi: 10.1002/jcla.24114. Epub 2021 Nov 19.

Direct Oral Anticoagulants Combined with Antiplatelet Therapy in the Treatment of Coronary Heart Disease: An Updated Meta-analysis.直接口服抗凝剂联合抗血小板治疗在冠心病治疗中的应用：一项更新的荟萃分析。

Drugs. 2021 Nov;81(17):2003-2016. doi: 10.1007/s40265-021-01637-4. Epub 2021 Nov 3.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验